Authors


Li Gong, PhD

Latest:

The Role of Pharmacogenetics in Precision Medicine

Clinicians have long been aware that patients do not uniformly respond to medications.


Tiffany Chow, PharmD Candidate

Latest:

The Ins and Outs of the Internship Application Process

As more pharmacists graduate from pharmacy schools, landing a job has become increasingly competitive.



Aislinn Antrim, Assistant Managing Editor

Latest:

NCPA 2024: Enabling Clinical Program Growth Requires a Change in Mindset

Changing the way pharmacists and pharmacy staff think about themselves is key, although providers, payers, and patients must also change how they view the value of pharmacy services.


Marina L. Sehman, RPh, PharmD

Latest:

Trends in First-Year Utilization Costs of HIV Medications

HIV is of interest among many in managed care. This paper focuses on the costs and demographic characteristics associated with new HIV therapy initiators.


Kelly Ratliff, President of US Bioservices

Latest:

Adherence to Oral Oncolytics Requires a Clinically Integrated Approach to Specialty Pharmacy

Despite initiatives that help patients maintain adherence, health care providers still need to leverage their collective resources and work together to overcome this tremendous hurdle in cancer care.


Octavian Barnett, PharmD Candidates 2018 Harrison School of Pharmacy, Auburn University.

Latest:

More Medications Means Changes to HIV Treatment Guidelines

The HIV treatment update includes more considerations for coinfected patients and pregnant women than the previously published 2011 guidelines.



Ken S. Latta, RPh, BS

Latest:

Improving Compounding Safety: New Regulations and Options for Institutional Insourcing

With increasing regulatory oversight for sterile compounding and a limited ability to assure the quality of compounded sterile products obtained from external sources, many hospital pharmacies are moving to insource these products.


Heidi Woodring, RN, CDE

Latest:

Insulin Pump Therapy and Continuous Glucose Monitoring

Insulin pump therapy and continuous glucose monitoring systems can be invaluable tools for patients with type 1 and type 2 diabetes.


Mark Borns, PharmD

Latest:

Biosimilars and Follow-on Biologics

Pharmacists must be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care.


Victor W. Nitti, MD

Latest:

Persistence With Mirabegron Versus Tolterodine in Patients With Overactive Bladder

In a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.


John R. White Jr, PA, PharmD

Latest:

First-Line Pharmacologic Treatment for Type 2 Diabetes: Optimizing Metformin Therapy

This article will briefly discuss some of these issues, including treatment of diabetes (focusing on the initial treatment choices) and individualization of therapy and adherence, and will introduce an extended-release metformin dosage form, Glumetza.



Brady Cole, RPh

Latest:

Community Pharmacist Shares Adventures From Ten Days in Quarantine

A community pharmacist reflects on spending time in quarantine after a positive COVID-19 test in the family.


Joshua D. Montney, PharmD, MBA, BCPS

Latest:

Risky Business: Overanticoagulation from High-Risk Antimicrobials and Warfarin

Warfarin is the most commonly prescribed anticoagulant in the United States, having been indicated for the treatment and prevention of venous thromboembolism and the prevention of thromboembolic complications.





Zachary Crouch

Latest:

INDUSTRY INTERNSHIPS: A DIFFERENT WAY TO SPEND YOUR SUMMER VACATION

Mr. Crouch is a PharmD candidate at Rutgers University, Class of 2009.




Parisa Vatanka, PharmD

Latest:

The Community Pharmacy Transformation

Safeway Pharmacy Offers an Invitation to Individuals with Passion to be a Part of the Community Pharmacy Transformation


Carolyn Hempel, PharmD, BCPS

Latest:

Emerging Therapies and the Expanding Role of Pharmacists in the Care of Patients with Heart Failure

This Continuing Education activity is supported by an educational grant from Novartis Pharmaceutical Corporation.



Peter Benko, PharmD Candidate Class of 2021, the University of Connecticut

Latest:

Dapagliflozin: Benefits in Heart Failure Patients With and Without Diabetes

A new study has found that patients with heart failure with reduced ejection fraction receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular events.


Laura Reagen

Latest:

The Women of Specialty Pharmacy: Industry Advocates, Entrepreneurs, Innovators

The first of a 2-part series on the influential women shaping the specialty pharmacy industry.


Jeffrey Fudin, BS, PharmD, DAIPM, FCCP, FASHP, FFSMB

Latest:

Be Mindful of DDIs Between Analgesics and Oral Cancer Drugs

Although these chemotherapy agents provide convenience and ease, they are subject to hepatic first-pass metabolism and enzymatic drug-drug interactions.


Mary E. Roth, PharmD, BCPS, CPP

Latest:

Transitions of Care for Patients with Atrial Fibrillation

Atrial fibrillation, the most common cardiac arrhythmia, is strongly associated with increased morbidity and mortality and has become a major global public health challenge.


Christina Ciccone, PharmD candidate

Latest:

Veterinary Medicine in Community Pharmacy

Student pharmacists speak to veterinary pharmacists and veterinarians about commonly prescribed medications for companion animals.